Literature DB >> 20118952

2009 FDA drug approvals.

Bethan Hughes.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20118952     DOI： 10.1038/nrd3101

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  24 in total

1.  Reinventing clinical trials.

Authors:  Malorye Allison
Journal:  Nat Biotechnol       Date:  2012-01-09       Impact factor: 54.908

Review 2.  Strategies and challenges for the next generation of therapeutic antibodies.

Authors:  Alain Beck; Thierry Wurch; Christian Bailly; Nathalie Corvaia
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

3.  New drug approval success rate in Europe in 2009.

Authors:  Hans-Georg Eichler; Bo Aronsson; Eric Abadie; Tomas Salmonson
Journal:  Nat Rev Drug Discov       Date:  2010-05       Impact factor: 84.694

4.  Fresh from the biologic pipeline-2009.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2010-04       Impact factor: 54.908

Review 5.  Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens.

Authors:  Biswadeep Das; Chayna Sarkar; Debasmita Das; Amit Gupta; Arnav Kalra; Shubham Sahni
Journal:  Ther Adv Infect Dis       Date:  2017-03-08

6.  Biopharmaceuticals and monoclonal antibodies in oncology trials--a cross-sectional analysis.

Authors:  T Janowitz
Journal:  Protein Eng Des Sel       Date:  2010-10-30       Impact factor: 1.650

7.  Drug discovery: lessons from evolution.

Authors:  John Warren
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

Review 8.  Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response.

Authors:  Hans-Georg Eichler; Eric Abadie; Alasdair Breckenridge; Bruno Flamion; Lars L Gustafsson; Hubert Leufkens; Malcolm Rowland; Christian K Schneider; Brigitte Bloechl-Daum
Journal:  Nat Rev Drug Discov       Date:  2011-07-01       Impact factor: 84.694

9.  Case report: artificial elevation of prothrombin time by telavancin.

Authors:  Derek F Amanatullah; Matthew J Lopez; Robert C Gosselin; Munish C Gupta
Journal:  Clin Orthop Relat Res       Date:  2012-11-06       Impact factor: 4.176

Review 10.  Self-assembling peptide-based building blocks in medical applications.

Authors:  Handan Acar; Samanvaya Srivastava; Eun Ji Chung; Mathew R Schnorenberg; John C Barrett; James L LaBelle; Matthew Tirrell
Journal:  Adv Drug Deliv Rev       Date:  2016-08-14       Impact factor: 15.470
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.